Evaluation of the therapeutic effect of treatment with intra-articular hyaluronic acid in knees for Kashin-Beck disease: A meta-analysis

Osteoarthritis and Cartilage

Volumn 22, Issue 6, 2014, Pages 718-725

  Yu, F F ^a   Xia, C T ^a   Fang, H ^a   Han, J ^a   Younus, M I ^a   Guo, X ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Intra articular hyaluronic acid (IAHA); Kashin Beck disease (KBD); Meta analysis

Indexed keywords

ASCORBIC ACID; HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 1BETA; KERATAN SULFATE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTHRALGIA; ARTICLE; BIBLIOGRAPHIC DATABASE; CLINICAL EFFECTIVENESS; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SAFETY; EVALUATION STUDY; FOLLOW UP; HUMAN; INJECTION SITE BLEEDING; JOINT EFFUSION; JOINT SWELLING; KASHIN BECK DISEASE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; THERAPY EFFECT; ADULT; AGE; AGED; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; FEMALE; INTRAARTICULAR DRUG ADMINISTRATION; JOINT CHARACTERISTICS AND FUNCTIONS; KASHIN-BECK DISEASE; KNEE; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PROGNOSIS; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; KASHIN-BECK DISEASE; KNEE JOINT; MALE; MIDDLE AGED; PAIN MEASUREMENT; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RANGE OF MOTION, ARTICULAR; TREATMENT OUTCOME;

EID: 84901824861     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2014.04.012     Document Type: Article

References (44)

1. Sokoloff L. The history of Kashin-Beck disease. NY State J Med 1989, 89(6):343-351.
2. Kolsteren P. Kashin-Beck disease. Ann Soc Belg Med Trop 1992, 72:81-91.
3. Hinsenkamp M. Kashin-Beck disease. Int Orthop 2001, 25(3). 133-133.
4. Mathieu F., Hinsenkamp M., Malaisse F. Kashin-Beck disease. Big Bone Dis 2008, 11-18.
5. Guo X. Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China. Int Orthop 2001, 25(3):147-150.
6. Hinsenkamp M., Mathieu F., Claus W., Collard J.F., DeMaertelaer V. Effects of physical environment on the evolution of Kashin-Beck disease in Tibet. Int Orthop 2009, 33(4):1085-1088.
7. Pasteels J., Liu F.D., Hinsenkamp M., Rooze M., Mathieu F., Perlmutter N. Histology of Kashin-Beck lesions. Int Orthop 2001, 25(3):151-153.
8. China Health Statistics Feed in 2012. (In Chinese). http://www.chinacdc.cn/tjsj/gjwstjsj/201206/W02010608368277572334.pdf.
9. Zou K., Liu G., Wu T., Du L. Selenium for preventing Kashin-Beck osteoarthropathy in children: a meta-analysis. Osteoarthritis and Cartilage 2009, 17(2):144-151.
10. Jirong Y., Huiyun P., Zhongzhe Y., Birong D., Weimin L., Ming Y., et al. Sodium selenite for treatment of Kashin-Beck disease in children: a systematic review of randomised controlled trials. Osteoarthritis and Cartilage 2012, 20(7):605-613.
11. Luo R., Liu G., Liu W., Pei F., Zhou Z., Li J., et al. Efficacy of celecoxib, meloxicam and paracetamol in elderly Kashin-Beck Disease (KBD) patients. Int Orthop 2011, 35(9):1409-1414.
12. Liu W., Liu G., Pei F., Liu Y., Zhou Z., Li J., et al. Kashin-Beck disease in Sichuan, China: report of a pilot open therapeutic trial. JCR: JClin Rheumatol 2012, 18(1):8-14.
13. Cao X.G., Lu X.Y., Xu G.Y., Zhang B.D., Liu Q., Jiao S.Q., et al. Clinical observation of therapeutic effect of three of medicine on Kashin-Beck disease. Chin J Endemiol 2004, 23(6):591-592. (In Chinese).
14. Effect and mechanism of selenium in the prevention and cure of 424 Kaschin-Beck's patients. Chin J Endemiol 1982, 1:145-164. The Yongshou Scientific Survey Group of Kaschin-Beck Disease, (In Chinese).
15. Niu G.H., Zhang B.Z., Li Z.X., Liu J.X., Zhu Z.Y., Hou S.F. Results of study of two years on the preventing and controlling Kashin-Beck's disease with selenium seen under X-rays and discussion of etiology. Chin J Endemiol 1984, 3:197-201. (In Chinese).
16. Niu G.H., Li Y.B., Sui L.Q., Zhang B.Z. Discussion on the efficacy of selenium for preventing Kashin-Beck disease. Chin J Public Health 1985, 4(5):21-23. (In Chinese).
17. Deng J.Y. Effect of sodium selenite oral application on Kashin-Beck disease, a three years observation. Chin J Endemiol 1988, 7:117-120. (In Chinese).
18. Niu G.H., Zhang B.Z., Hou S.F. Effect of semis-dosage selenium on controlling of Kashin-Beck disease. Chin J Endemiol 1990, 9(2):99-100. (In Chinese).
19. Mathieu F., Suetens C., Begaux F., De Martelaer V., Hinsenkamp M. Effects of physical therapy on patients with Kashin-Beck disease in Tibet. Int Orthop 2001, 25(3):191-193.
20. Tu Z.M., Yang L.G., Zhou J.F., Gao D.L., Dong S., Xie J.J., et al. Comparison of treatment results of arthroscopic knee debridement alone with a combination of arthroscopic debridement and drilling decompression in knee Kaschin-Beck disease. China J Endosc 2009, 15(4):371-374. (In Chinese).
21. Yi Z., Ling M., Luo Z.Q., Chang Y.H., Lei H.J., Ma Z.S., et al. Observation on treatment result of arthroscopic knee clearing and reconstructing operation in Kaschin-Beck disease. China J Endosc 2012, 12(9):937-940. (In Chinese).
22. Yang L.G., Tu Z.M., Zhou J.F., Gao D.L., Dong S., Ren J.L., et al. Surgical treatment on the adult Kaschin Beck disease. China J Endosc 2009, 3(4):459-462. (In Chinese).
23. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006, (Review).
24. Wang C.T., Lin J., Chang C.J., Lin Y.T., Hou S.M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee A meta-analysis of randomized controlled trials. JBone Joint Surg 2004, 86(3):538-545.
25. Bannuru R.R., Natov N.S., Dasi U.R., Schmid C.H., McAlindon T.E. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis: meta-analysis. Osteoarthritis and Cartilage 2011, 19(6):611-619.
26. Miller L.E., Block J.E. US-approved intra-articular hyaluronic acid injections are safe and effective in patients with knee osteoarthritis: systematic review and meta-analysis of randomized, Saline-Controlled trials. Clinical medicine insights. Arthritis and Musculoskelet Disord 2012, 6:57-63.
27. Lo G.H., LaValley M., McAlindon T., Felson D.T. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003, 290(23):3115-3121.
28. Modawal A., Ferrer M., Choi H.K., Castle J.A. Hyaluronic acid injections relieve knee pain. JFam Pract 2005, 54(9):758.
29. Arrich J., Piribauer F., Mad P., Schmid D., Klaushofer K., Müllner M. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. Can Med Assoc J 2005, 172(8):1039-1043.
30. Bannuru R.R., Natov N.S., Obadan I.E., Price L.L., Schmid C.H., McAlindon T.E. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Care Res 2009, 61(12):1704-1711.
31. Yang J.B. The discussion on the medication for adult Kashin-Beck disease. Chin J Endemiol 2005, 24(1):87-90. (In Chinese).
32. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151(4):264-269.
33. Diagnostic Criteria of Kashin-Beck Disease. http://www.moh.gov.cn/zwgkzt/s9500/201212/34063.shtml.
34. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J.M., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17(1):1-12.
35. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Psychology Press.
36. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
37. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
38. Xu P., Guo X., Jin W.Z., Yao J.F., Wang J.H., Zhang F.Q., et al. Curative effects of intra-articular injections of sodium hyaluronate to treat Kaschin-Beck disease. Chin J Endemiol 2004, 23(6):588-590. (In Chinese).
39. Yu Y.X., Guo D.W., Huang L.Q., Xue R.H., Wang Z.L. Intra-articular sodium hyaluronate injection for treating knee osteoarthritis. Chin J Endemiol 2011, 26(3):185-187. (In Chinese).
40. Tang X., Pei F.X., Zhou K.Z., Liu G., Shen B., Kang P.D., et al. Arandomized, single-blind comparison of the efficacy and tolerability of hyaluronate acid and meloxicam in adult patients with Kashin-Beck disease of the knee. Clin Rheumatol 2012, 31(7):1079-1086.
41. Yu F.F., Xia C.T., Fang H., Guo X. The long-term therapeutic effect of sodium hyaluronic acid on the adults with Kashin-Beck disease assessed by joint dysfunction index. Chin J Endemiol 2014, (In Chinese), (in press).
42. Liu L.J., Zhang X.H., Wei D.H., Wang H.Y., Xu S.L., Zha X.S.Z., et al. The serum cytokine levels and efficacy of therapeutic trajectory for Kashin Beck disease in Tibet. JTibet Univ 2011, 26(2):56-59. (In Chinese).
43. He C.M., Guo X. The content of hyaluronic acid, CD44, keratan sulfate in adult Kashin Beck disease injecting sodium hyaluronate. Chin J Clin Electron (Electronic Edition) 2011, 5(16):4852-4854. (In Chinese).
44. He C.M. The content of Serum NO, TNF-α and IL-1β in adult Kashin Beck disease injecting sodium hyaluronate. Shaanxi Med J 2011, 40(10):1401-1402. (In Chinese).